US researchers have developed an antiviral chewing gum using lablab beans that can reduce viral loads of herpes (HSV-1, HSV-2 ...
In today's interconnected world, infectious diseases pose an escalating threat, as demonstrated by the coronavirus pandemic ...
For decades, the human niche for viruses related to smallpox has remained mostly empty. Since eradicating smallpox, only rare ...
Its overdependence on vaccines leaves the country vulnerable to bioterrorism.
Low vaccination rates for influenza viruses and the lack of an HSV vaccine underscore the need for a new approach to reduce viral transmission. Researchers have now used a clinical-grade antiviral ...
Federal officials cited the end of the Covid-19 pandemic in halting the research. But much of the work was focused on ...
The strongest set of evidence to date indicates that people who had a shingles vaccine had significantly lower odds of ...
The shingles vaccine may have a protective effect against dementia, write doctors Christopher Worsham and Anupam Jena.
Several previous studies have suggested that shingles vaccinations might reduce dementia risk, but most could not exclude the ...
Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.
A team of US researchers have developed a new antiviral chewing gum that showed the potential to substantially reduce viral loads of two herpes simplex viruses and two influenza A strains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results